166 related articles for article (PubMed ID: 34628359)
21. Can we predict histological outcome of distinctive cohorts of patients with glandular cell abnormalities on ThinPrep Papanicolaou testing based on human papillomavirus status, age, and associated squamous abnormalities?
Harbhajanka A; Dahoud W; Michael CW
Diagn Cytopathol; 2019 Oct; 47(10):1028-1036. PubMed ID: 31359607
[TBL] [Abstract][Full Text] [Related]
22. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review.
Graham SV
Clin Sci (Lond); 2017 Sep; 131(17):2201-2221. PubMed ID: 28798073
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus.
Cox JT
Baillieres Clin Obstet Gynaecol; 1995 Mar; 9(1):1-37. PubMed ID: 7600720
[TBL] [Abstract][Full Text] [Related]
24. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
[TBL] [Abstract][Full Text] [Related]
25. The Reservoir of Persistent Human Papillomavirus Infection; Strategies for Elimination Using Anti-Viral Therapies.
Zheng K; Egawa N; Shiraz A; Katakuse M; Okamura M; Griffin HM; Doorbar J
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215808
[TBL] [Abstract][Full Text] [Related]
26. Persistence of human papillomavirus infection: keys to malignant progression.
Bodily J; Laimins LA
Trends Microbiol; 2011 Jan; 19(1):33-9. PubMed ID: 21050765
[TBL] [Abstract][Full Text] [Related]
27. Increase of integration events and infection loads of human papillomavirus type 52 with lesion severity from low-grade cervical lesion to invasive cancer.
Cheung JL; Cheung TH; Tang JW; Chan PK
J Clin Microbiol; 2008 Apr; 46(4):1356-62. PubMed ID: 18272718
[TBL] [Abstract][Full Text] [Related]
28. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.
Pyeon D; Newton MA; Lambert PF; den Boon JA; Sengupta S; Marsit CJ; Woodworth CD; Connor JP; Haugen TH; Smith EM; Kelsey KT; Turek LP; Ahlquist P
Cancer Res; 2007 May; 67(10):4605-19. PubMed ID: 17510386
[TBL] [Abstract][Full Text] [Related]
29. Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions.
Schmitt M; Depuydt C; Benoy I; Bogers J; Antoine J; Pawlita M; Arbyn M;
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):406-14. PubMed ID: 23334590
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility of epithelial cells cultured from different regions of human cervix to HPV16-induced immortalization.
Deng H; Hillpot E; Yeboah P; Mondal S; Woodworth CD
PLoS One; 2018; 13(6):e0199761. PubMed ID: 29944714
[TBL] [Abstract][Full Text] [Related]
31. Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer.
Chung SH; Wiedmeyer K; Shai A; Korach KS; Lambert PF
Cancer Res; 2008 Dec; 68(23):9928-34. PubMed ID: 19047174
[TBL] [Abstract][Full Text] [Related]
32. In vivo cyclin E expression as a marker for early cervical neoplasia.
Quade BJ; Park JJ; Crum CP; Sun D; Dutta A
Mod Pathol; 1998 Dec; 11(12):1238-46. PubMed ID: 9872657
[TBL] [Abstract][Full Text] [Related]
33. The role of human papillomaviruses in oncogenesis.
Mighty KK; Laimins LA
Recent Results Cancer Res; 2014; 193():135-48. PubMed ID: 24008297
[TBL] [Abstract][Full Text] [Related]
34. Vaginal Neoplasia Induced by an Unusual Papillomavirus Subtype in a Woman with Inherited Chromosomally Integrated Human Herpesvirus Type 6A.
Pichon M; Gaymard A; Lebail-Carval K; Frobert E; Beaufils E; Chene G; Tommasino M; Lina B; Gaucherand P; Gautheret-Dejean A; Bonnafous P; Gheit T; Buenerd A; Lamblin G; Mekki Y
Gynecol Obstet Invest; 2017; 82(3):307-310. PubMed ID: 28380476
[TBL] [Abstract][Full Text] [Related]
35. [Epidemiology of cervical papillomavirus infections. Recent knowledge].
Mougin C; Dalstein V; Prétet JL; Gay C; Schaal JP; Riethmuller D
Presse Med; 2001 Jun; 30(20):1017-23. PubMed ID: 11433694
[TBL] [Abstract][Full Text] [Related]
36. The prevalence, genotype distribution of human papillomavirus and cervical cytology in Wenzhou, China: a retrospective research of 7391 cases.
Lin Q; Lin X; Zhuang X; Tang Y; Zhao Z
Diagn Cytopathol; 2021 Feb; 49(2):211-218. PubMed ID: 32965784
[TBL] [Abstract][Full Text] [Related]
37. Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model.
Tewari KS; Taylor JA; Liao SY; DiSaia PJ; Burger RA; Monk BJ; Hughes CC; Villarreal LP
Gynecol Oncol; 2000 Apr; 77(1):137-48. PubMed ID: 10739703
[TBL] [Abstract][Full Text] [Related]
38. Detection of High-Risk Human Papillomaviruses in the Prevention of Cervical Cancer in India.
Baskaran K; Kumar PK; Karunanithi S; Sethupathy S; Thamaraiselvi B; Swaruparani S
Asian Pac J Cancer Prev; 2015; 16(18):8187-90. PubMed ID: 26745058
[TBL] [Abstract][Full Text] [Related]
39. Detection of HPV-induced cervical (pre) neoplastic lesions: a tissue microarray (TMA) study.
Arafa M; Boniver J; Delvenne P
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):422-32. PubMed ID: 18542030
[TBL] [Abstract][Full Text] [Related]
40. HPV E6 inhibits E6AP to regulate epithelial homeostasis by modulating keratinocyte differentiation commitment and YAP1 activation.
Yin W; Egawa N; Zheng K; Griffin H; Tian P; Aiyenuro A; Bornstein J; Doorbar J
PLoS Pathog; 2023 Jun; 19(6):e1011464. PubMed ID: 37379354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
